Search Results - "Top, Karina"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    The use and impact of monoclonal antibody biologics during pregnancy by Pham-Huy, Anne, Top, Karina A, Constantinescu, Cora, Seow, Cynthia H, El-Chaâr, Darine

    “…Monoclonal antibody biologics, also known as biologics, have revolutionized the treatment and quality of life of many patients with inflammatory and autoimmune…”
    Get full text
    Journal Article
  5. 5

    A narrative review of vaccine pharmacovigilance during mass vaccination campaigns: Focus on myocarditis and pericarditis after COVID‐19 mRNA vaccination by Piché‐Renaud, Pierre‐Philippe, Morris, Shaun K., Top, Karina A.

    Published in British journal of clinical pharmacology (01-03-2023)
    “…Vaccines have had a tremendous impact on reducing the burden of infectious diseases; however, they have the potential to cause adverse events following…”
    Get full text
    Journal Article
  6. 6

    Anaphylaxis: Revision of the Brighton collaboration case definition by Gold, Michael S., Amarasinghe, Ananda, Greenhawt, Matthew, Kelso, John M., Kochhar, Sonali, Yu-Hor Thong, Bernard, Top, Karina A., Turner, Paul J., Worm, Margitta, Law, Barbara

    Published in Vaccine (06-04-2023)
    “…The Brighton Collaboration (BC) has formulated a number of case definitions which have primarily been applied to adverse events of special interest in the…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes by Mehrabadi, Azar, Dodds, Linda, MacDonald, Noni E, Top, Karina A, Benchimol, Eric I, Kwong, Jeffrey C, Ortiz, Justin R, Sprague, Ann E, Walsh, Laura K, Wilson, Kumanan, Fell, Deshayne B

    “…IMPORTANCE: Seasonal influenza vaccination in pregnancy can reduce influenza illness among pregnant women and newborns. Evidence is limited on whether seasonal…”
    Get full text
    Journal Article
  10. 10

    Healthcare providers’ interpretations of product labelling information developed through a consensus stakeholder approach by Manca, Terra A., Graham, Janice E., MacDonald, Noni E., Top, Karina A.

    Published in Vaccine (06-05-2021)
    “…•Survey of clinicians comparing revised product labels to existing labels.•Healthcare providers preferred stakeholder-developed labels over existing…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Risk of seizures after immunization in children with epilepsy: a risk interval analysis by Top, Karina A, Brna, Paula, Ye, Lingyun, Smith, Bruce

    Published in BMC pediatrics (11-04-2018)
    “…In children with epilepsy, fever and infection can trigger seizures. Immunization can also induce inflammation and fever, which could theoretically trigger a…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety Network by Soe, Phyumar, Wong, Hubert, Naus, Monika, Muller, Matthew P., Vanderkooi, Otto G., Kellner, James D., Top, Karina A., Sadarangani, Manish, Isenor, Jennifer E., Marty, Kimberly, De Serres, Gaston, Valiquette, Louis, McGeer, Allison, Bettinger, Julie A.

    Published in Vaccine (11-07-2024)
    “…This study examined short-to-medium term safety of COVID-19 vaccines among adults aged ≥65 years using the Canadian National Vaccine Safety Network active…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Governing off-label vaccine use: An environmental scan of the Global National Immunization Technical Advisory Group Network by Top, Karina A., Esteghamati, Abdoulreza, Kervin, Melissa, Henaff, Louise, Graham, Janice E., MacDonald, Noni E.

    Published in Vaccine (29-01-2020)
    “…•Vaccine recommendations that differ from product information are termed “off-label”•We surveyed low-, middle- and high-income countries with immunization…”
    Get full text
    Journal Article